Amikacin Liposome Inhalation Suspension 72770-7032-01
- Manufacturer
- Resilience Biotechnologies Inc
- Dosage Form
- Suspension
- Product Type
- Drug For Further Processing
- Marketing Start
- October 12, 2018
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amikacin | 590 mg/8.4mL |
Selected Package
72770-7032-01Selected8.4 mL in 1 VIAL (72770-7032-1)